![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » MicroGEM’s COVID-19 Saliva Test Gets FDA’s Emergency Use Authorization
MicroGEM’s COVID-19 Saliva Test Gets FDA’s Emergency Use Authorization
MicroGEM U.S. has received an Emergency Use Authorization from the FDA for its MicroGEM Sal6830 SARS-CoV-2 saliva test for COVID-19.
The assay is authorized for the qualitative detection of nucleic acid from SARS-CoV-2 in saliva specimens from individuals suspected by a healthcare provider of COVID-19 infection.
Processing of the samples is restricted to laboratories that are authorized to perform high, moderate or waived complexity tests — that is, tests approved for waiver under the Clinical Laboratory Improvement Amendments (CLIA) criteria.
MicroGEM’s headquarters are in Southampton, UK, and it has a U.S. office in Charlottesville, Va.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct